Today we are witnessing several trends that are shaping the future of our industry. These include great developments in the areas of gene therapy, biologics, proteomics and new improved medicines and devices.
The commercial competition is great in both the pharmaceutical and biotechnology sectors and steps still have to be taken to bring together great collaborations to produce new innovative medicines that have shortened life cycles for branded drugs. Politically there are some developing issues around the world leading to focus and attention in the disease areas of HIV and oncology, for example. Specialist hospital injectables are recognisably a growing industry within this.
Blockbuster patent expirations, fewer drugs in the pipeline, rising numbers of generics and regulatory pressures are causing the pharmaceutical industry to question the fundamentals on which it has relied. Generic companies have the opportunity to align their marketing competencies in order to realize the opportunities of existing and evolving product lines.
|